46th DIA Annual Meeting
|Event Date/Time: Jun 13, 2010||End Date/Time: May 17, 2010|
At the conclusion of this meeting, participants should be able to:
Describe the current regulatory and public policy environment pertaining to pharmaceuticals with an emphasis on the Food and Drug Administration;
Discuss the international regulations and economic factors that impact the global biopharmaceutical industry;
Recognize the challenges facing the FDA and the pharmaceutical industry in areas such as research study design and statistical methodology;
Recognize state-of-the-art clinical and statistical systems and implementations;
Recognize the written and communication skills needed to promote your career and your companys objectives;
Enhance your working relationship with colleagues, both locally and internationally;
Describe legal, advertising, and marketing issues related to providing product information;
Discuss statistics, economics, and quality of life science;
Enhance your knowledge of risk assessment and management in the areas such as computer systems validation and drug safety and pharmacovigilance;
Discuss issues in safety reporting, data analysis, epidemiology, and regulations regarding adverse events.
WHO SHOULD ATTEND
This program is designed for the full continuum of disciplines in the pharmaceutical and related industries to improve your understanding and skills as related to issues and solutions for a variety of pharmaceutical development interest areas.